Burkbauer, L., Goldbach, M. M., & Tchou, J. C. (2021). ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis. Ann Surg Oncol.
Citação norma ChicagoBurkbauer, Laura, Macy M. Goldbach, and Julia C. Tchou. "ASO Author Reflections: Objective Response Rate After Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis." Ann Surg Oncol 2021.
Citação norma MLABurkbauer, Laura, Macy M. Goldbach, and Julia C. Tchou. "ASO Author Reflections: Objective Response Rate After Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis." Ann Surg Oncol 2021.